Previous 10 | Next 10 |
BOULDER, Colo., Jan. 09, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, today announced that preliminary, unaudited revenue for the full year 2022 is expected to be at the high end of its guidance range of $93 to $98 million, reflecting approximately 20% year-over-ye...
Summary We dive under the hood of one of the most controversial exchange-traded funds, analyzing their moves based on recently disclosed 13F filing data. Cathie Wood is a uniquely divisive figure in the world of finance made famous by her "disruptive innovation" investment philosophy, w...
BOULDER, Colo., Dec. 29, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, today announced that the company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference. SomaLogic will present at the conference on Thursday, January 12, 2023 ...
TOKYO and BOULDER, Colo., Dec. 19, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomic technology, announced today that Tokyo-based FonesLife Corporation, will be the first SomaLogic™ Certified Site in Japan. The new site will offer the 7,000-plex SomaScan ® Assay in t...
BOULDER, Colo., Dec. 07, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, announced today the full-scale global launch of the SomaLogic™ Certified Site program, which will allow institutions around the world to run the 7,000-plex SomaScan ® Assay ...
BOULDER, Colo., Nov. 17, 2022 (GLOBE NEWSWIRE) -- In an upcoming randomized, controlled study enrolling 248 physicians, researchers are measuring whether SomaLogic’s SomaSignal ® tests aid physicians in the risk stratification for cardiovascular disease of their patients. Re...
SomaLogic, Inc. (SLGC) Q3 2022 Earnings Conference Call November 14, 2022 08:30 AM ET Company Participants Marissa Bych - Investor Relations, Gilmartin Group LLC Roy Smythe - Chief Executive Officer Shaun Blakeman - Chief Financial Officer Conference Call P...
SomaLogic press release ( NASDAQ: SLGC ): Q3 GAAP EPS of -$0.18 beats by $0.02 . Revenue of $41.7M (+108.6% Y/Y). For further details see: SomaLogic GAAP EPS of -$0.18 beats by $0.02, revenue of $41.7M
Third quarter 2022 revenue of $41.7 million , bringing year to date revenue to $78.8 million . Core life science revenue of $20.5 million, representing an increase of 2.9% year-over-year and 45.4% compared to the last quarter. On track to reduce opera...
Looking For Penny Stocks to Buy? Have You Looked At the Options Yet? There are plenty of ways to find penny stocks to buy. You could hunt for momentum using a penny stock screener. You could play the stock market game by analyzing social sentiment. There are also ways to find names ...
News, Short Squeeze, Breakout and More Instantly...
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health , today announced that its stockholders voted to approve all proposals required to be approved in...
SomaLogic Stockholders Vote to Approve Standard BioTools Transaction at Special Meeting PR Newswire Stockholder Approval Represents Key Milestone Toward Completion of Standard BioTools Transaction Combination Will Create a Diversified Leader in Life Sciences Tools ...
Believes All SomaLogic Directors – Robert Barchi , Thomas Carey , Eli Casdin , Troy Cox , Kathy Hibbs , Anne Margulies , Tycho Peterson , Richard Post and Jason Ryan – Have Betrayed Shareholders by Delaying the Special Meeting Five Times so the Bo...